|
|
|
Ipsen S.A. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Ipsen S.A. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Ipsen S.A. - Product Pipeline Review - 2013” provides data on the Ipsen S.A.’s research and development focus. The report includes information on
|
read more...
|
$1,500.00
|
|
ImmunoGen, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
ImmunoGen, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “ImmunoGen, Inc. - Product Pipeline Review - 2013” provides data on the ImmunoGen, Inc.’s research and development focus. The report includes information on
|
read more...
|
$1,500.00
|
|
ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary ImmunoCellular Therapeutics, Ltd. (IMCU) is a clinical-stage biotechnology company. It develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. The company’s immunotherapies
|
read more...
|
$750.00
|
|
InSightec Ltd. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary InSightec Ltd. (InSightec) is a medical device company. The company develops and markets medical devices for the diagnostic markets. Its products include ExAblate O.R., ExAblate neuro and system components. The company’s ExAblate neuro integrates ultrasound
|
read more...
|
$750.00
|
|
Insulet Corporation (PODD) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Insulet Corporation (Insulet) is a medical device company. The company develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin
|
read more...
|
$750.00
|
|
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Isis Pharmaceuticals, Inc.’s research and development focus. The report
|
read more...
|
$1,500.00
|
|
Innocoll Technologies Ltd - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Innocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets drug delivery devices for the pharmaceutical and medical markets. Its products include cogenzia, xaracoll, gentamicin surgical implant, procoll and durieva. The
|
read more...
|
$750.00
|
|
InsightMRI - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary InsightMRI is a medical device company. The company provides medical devices for the diagnostic imaging markets. Its human imaging products consist of breast coil, insight head coil, insight wrist coil, insight ankle coil and the
|
read more...
|
$750.00
|
|
Immunomedics, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
Immunomedics, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Immunomedics, Inc. - Product Pipeline Review - 2013” provides data on the Immunomedics, Inc.’s research and development focus. The report includes information on
|
read more...
|
$1,500.00
|
|
Tornier, Inc. - Product Pipeline Analysis, 2013 Update
4/17/2013 | published by: GlobalData
Summary Tornier, Inc. (Tornier) is a medical device manufacturer. The company designs, manufactures and markets devices for joint replacement and soft tissue repair that allow surgical specialists to change patients’ lives by reinstating movement and physical
|
read more...
|
$750.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
General Company Reports
